GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, CYP3A4, DHFR, F10, F3, FABP3, FABP4, FLT3, GRIN2B, GSK3B, HSD11B1, HSD17B3, KCNH2, KDR, MAOA, MET, PPARA, PTGS2, SRC, TRPV1, XDH |
10.7623 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CYP1B1, F3, FLT3, GRIN2B, GSK3B, IDO1, IGF1R, KDR, MAP2K1, MET, PIM1, PPARA, PTGS2, RELA, SRC, TRPV1, XDH |
7.66656 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, APP, CBR1, CYP19A1, CYP1B1, CYP3A4, FABP3, FABP4, HSD11B1, HSD17B3, MET, PPARA, PTGES, PTGS2, TRPV1 |
7.4378 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX12, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CBR1, CYP19A1, CYP1B1, CYP3A4, DHFR, FABP3, HSD17B3, IDO1, PIM1, PPARA, PTGES, PTGS2, XDH |
7.4378 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CYP1B1, F10, F3, FLT3, KDR, MAP2K1, MAP3K7, MET, PTGS2, RELA, SRC, XDH |
7.18829 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CYP19A1, CYP1B1, F10, F3, FLT3, GSK3B, KDR, MAP2K1, MAP3K7, MET, PTGS2, RELA, SRC, XDH |
7.05203 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CA2, CA7, CYP19A1, CYP1B1, F10, F3, FLT3, GSK3B, KDR, MAP2K1, MAP3K7, MET, PTGS2, RELA, SRC, XDH |
7.05203 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CYP1B1, F3, FLT3, GSK3B, IDO1, IGF1R, KDR, MAP2K1, MET, PIM1, PTGS2, RELA, SRC, TRPV1, XDH |
6.86649 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, APP, AR, AXL, CA2, CYP1B1, DHFR, FABP3, FABP4, FLT3, GRIN2B, GSK3B, IDO1, IGF1R, KDR, NR3C1, PPARA, PTGES, PTGS2, RELA, SRC, TRPV1 |
6.43803 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CYP19A1, CYP1B1, CYP3A4, DHFR, F10, F3, FABP3, FABP4, FLT3, GRIN2B, GSK3B, HSD11B1, HSD17B3, IDO1, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, PTGS2, RELA, SRC, TOP1, TRPV1, XDH |
6.3834 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, APP, AR, AXL, CA2, CYP1B1, DHFR, FABP3, FABP4, FLT3, GRIN2B, GSK3B, IDO1, IGF1R, KCNH2, KDR, NR3C1, PPARA, PTGES, PTGS2, RELA, SRC, TOP1, TRPV1 |
6.25978 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, DHFR |
6.24839 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, CYP1B1, F3, FLT3, GSK3B, IDO1, IGF1R, KDR, MAP2K1, PIM1, PTGS2, RELA, SRC, TRPV1, XDH |
6.24839 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX12, ALOX15, ALOX5, CBR1, CYP19A1, CYP1B1, CYP3A4, DHFR, GSK3B, HSD11B1, HSD17B3, IDO1, MAOA, PTGS2, XDH |
6.12985 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CYP19A1, CYP1B1, F10, F3, FABP3, FLT3, GRIN2B, GSK3B, IDO1, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGS2, RELA, SRC, TRPV1, XDH |
5.9344 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CYP19A1, CYP1B1, DHFR, F10, F3, FABP3, FABP4, FLT3, GRIN2B, GSK3B, IDO1, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGS2, RELA, SRC, TRPV1, XDH |
5.9344 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, APP, AR, AXL, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, F10, F3, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MET, PPARA, PTGS2, SRC, TRPV1 |
5.84051 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, GSK3B, IDO1, IGF1R, KDR, MET, PIM1, PPARA, PTGS2, RELA, SRC |
5.83223 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.82884 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, DHFR, FABP3, GRIN2B, GSK3B, IDO1, IGF1R, NR3C1, PPARA, PTGES, PTGS2, RELA, SRC, TRPV1 |
5.78354 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, ALOX12, APP, AR, CYP1B1, F3, FABP3, FLT3, IDO1, IGF1R, KDR, MAP2K1, PIM1, PTGES, PTGS2, RELA, SRC, XDH |
5.78354 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, CA2, CYP1B1, FABP4, KDR, PTGES, PTGS2, RELA, SRC |
5.77688 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, KCNH2, KDR, NR3C1, PTGS2, RELA, SRC, TRPV1 |
5.65775 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CYP1B1, F10, F3, FLT3, GSK3B, KDR, MAP2K1, MAP3K7, MET, PTGS2, RELA, SRC, XDH |
5.53673 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, GSK3B, IDO1, IGF1R, KDR, MET, PIM1, PTGS2, RELA, SRC |
5.53673 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, CYP1B1, DHFR, FABP3, GRIN2B, KCNH2, KDR, NR3C1, PTGS2, RELA, SRC, TOP1, TRPV1 |
5.52266 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CBR1, CYP1B1, PTGES, PTGS2 |
5.4125 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1B1, PTGES, PTGS2 |
5.39771 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1B1, PTGES, PTGS2 |
5.24492 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, FLT3, GRIN2B, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
5.22176 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CYP1B1, F10, F3, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PTGS2, RELA, SRC, XDH |
5.18415 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP3A4, DHFR, HSD17B3, IDO1, PTGES, PTGS2 |
5.10168 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ALOX12, APP, CYP19A1, DHFR, F3, FABP4, GSK3B, IDO1, IGF1R, MAP2K1, MAP3K7, MET, PPARA, PTGS2, RELA, SRC, XDH |
5.10168 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, APP, AR, AURKB, AXL, CYP19A1, CYP1B1, DHFR, FABP3, FABP4, GRIN2B, GSK3B, IDO1, IGF1R, KCNH2, KDR, MAP2K1, MET, NR3C1, PIM1, PPARA, PTGES, PTGS2, RELA, SRC, TRPV1, XDH |
5.08627 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX12, ALOX15, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CBR1, CYP19A1, CYP1B1, CYP3A4, DHFR, F10, FABP3, FABP4, FLT3, GRIN2B, GSK3B, HSD17B3, IDO1, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, PTGS2, RELA, SRC, TOP1, XDH |
5.0001 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, GSK3B, IGF1R, PPARA, PTGS2, RELA, SRC, TRPV1 |
5.0001 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, GSK3B, IDO1, IGF1R, KDR, PIM1, PTGS2, RELA, SRC |
4.88406 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, ALOX12, APP, AXL, CA12, CA2, CA7, CACNA1C, FABP3, FABP4, FLT3, GRIN2B, KCNH2, MET, SRC, TRPV1 |
4.7957 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CYP1B1, DHFR, F10, F3, FABP3, FABP4, FLT3, GRIN2B, GSK3B, IDO1, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, NR3C1, PPARA, PTGES, PTGS2, RELA, SRC, TOP1, TRPV1 |
4.77779 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CYP19A1, CYP1B1, DHFR, FABP3, FABP4, GRIN2B, GSK3B, IDO1, IGF1R, KCNH2, KDR, MAP2K1, MET, NR3C1, PIM1, PPARA, PTGES, PTGS2, RELA, SRC, TRPV1, XDH |
4.75192 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX12, ALOX15, ALOX5, PTGES, PTGS2 |
4.75174 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, DHFR, FLT3, GRIN2B, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, PTGS2, SRC, TOP1, XDH |
4.75174 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CYP1B1, F10, F3, FABP4, FLT3, GSK3B, IDO1, KDR, MAP2K1, MAP3K7, MET, PTGS2, RELA, SRC, XDH |
4.7478 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ALOX12, APP, CACNA1C, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, PTGS2, SRC |
4.71957 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, F10, F3, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PTGS2, RELA, SRC, XDH |
4.71957 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, APP, AR, AXL, CYP1B1, FABP4, FLT3, GSK3B, IGF1R, KDR, NR3C1, PTGS2, RELA, SRC, TRPV1 |
4.71957 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, F10, F3, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PTGS2, RELA, SRC, XDH |
4.62234 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1B1, FABP3, PPARA, PTGES, PTGS2 |
4.58872 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ALOX12, APP, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, PTGS2, SRC |
4.58872 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5, PTGS2 |
4.57007 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, APP, AR, AXL, CACNA1C, CYP19A1, CYP1B1, F10, F3, FABP4, GRIN2B, IDO1, IGF1R, KCNH2, MET, PIM1, PPARA, PTGS2, RELA, SRC, TOP1, TRPV1 |
4.55032 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, DHFR, FLT3, GRIN2B, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, PTGS2, SRC, TOP1, XDH |
4.49994 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX12, ALOX15, APP, CYP19A1, CYP1B1, CYP3A4, DHFR, HSD17B3, MAOA |
4.45203 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, APP, AR, AXL, CYP1B1, FABP4, FLT3, GSK3B, IGF1R, KCNH2, KDR, NR3C1, PTGS2, RELA, SRC, TRPV1 |
4.37677 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ALOX12, APP, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, PTGS2, SRC |
4.321 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1B1, PTGES, PTGS2 |
4.30025 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APP, AR, CA2, FABP3, FLT3, GSK3B, IGF1R, NR3C1, PPARA, PTGS2, RELA, SRC, TRPV1 |
4.29948 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, FLT3, GRIN2B, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
4.28564 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, APP, AR, AXL, CA2, CYP1B1, F3, IDO1, KDR, MAP2K1, MAP3K7, MET, PIM1, PTGS2, RELA, SRC, TRPV1 |
4.21747 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, DHFR, HSD17B3 |
4.19939 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ALOX12, APP, AR, AXL, CA2, CACNA1C, CYP1B1, F3, GSK3B, IDO1, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, PTGS2, RELA, SRC, TRPV1, XDH |
4.18433 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CYP1B1, DHFR, FABP4, FLT3, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, NR3C1, PTGS2, RELA, SRC, TRPV1 |
4.16734 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CBR1, CYP1B1, PTGES, PTGS2 |
4.16734 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, AR, CA2, CYP1B1, DHFR, FLT3, NR3C1, PTGES, PTGS2, RELA, SRC, TRPV1 |
4.08238 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
4.03288 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, MAP3K7, NR3C1, PIM1, PPARA, RELA, SRC |
4.01048 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ALOX12, APP, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, MET, PTGS2, SRC |
4.00671 |
[BP] GO:0034097 |
response to cytokine
|
ALOX15, AXL, FABP4, FLT3, GSK3B, PTGES, PTGS2, RELA, SRC, TRPV1 |
3.9805 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1B1, FABP3, IDO1, PPARA, PTGES, PTGS2 |
3.97733 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CYP1B1, GSK3B, IGF1R, NR3C1, PTGS2, RELA, SRC, TRPV1 |
3.93866 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DHFR, FABP3, FLT3, GSK3B, IGF1R, PPARA, PTGS2, RELA, SRC, TRPV1 |
3.90603 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CYP19A1, CYP1B1, DHFR, F10, F3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, MAP2K1, MAP3K7, MET, PPARA, PTGS2, RELA, SRC, XDH |
3.88778 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1B1, CYP3A4, HSD11B1, HSD17B3 |
3.88778 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.87897 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B3 |
3.87897 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.84404 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, APP, AR, AURKB, AXL, CBR1, CYP19A1, CYP1B1, CYP3A4, DHFR, F10, F3, FABP3, FABP4, FLT3, GRIN2B, GSK3B, HSD11B1, HSD17B3, IDO1, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, PTGS2, RELA, SRC, TOP1, TRPV1, XDH |
3.83508 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, APP, AR, AURKB, AXL, CBR1, CYP19A1, CYP1B1, CYP3A4, DHFR, F10, F3, FABP3, FABP4, FLT3, GRIN2B, GSK3B, HSD11B1, HSD17B3, IDO1, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, PTGS2, RELA, SRC, TOP1, TRPV1, XDH |
3.82053 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, F3, FABP4, IDO1, KDR, MAP2K1, MET, PPARA, PTGS2, RELA |
3.81139 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, APP, CA12, CA2, CA7, CACNA1C, FABP3, FABP4, GRIN2B, KCNH2, MET, TRPV1 |
3.78961 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, AR, FLT3, KDR, MAP2K1, MAP3K7, SRC, XDH |
3.78735 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, FLT3, GSK3B, IGF1R, KDR, PIM1, SRC |
3.76467 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX12, ALOX15, ALOX5, CBR1, CYP1B1, CYP3A4, FABP3, FABP4, MET, PPARA, PTGES, PTGS2 |
3.70044 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AR, CA2, FABP3, FLT3, NR3C1, PPARA, PTGS2, RELA, SRC, TRPV1 |
3.69979 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX12, ALOX15, PTGES, PTGS2 |
3.6901 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DHFR, FABP3, FLT3, GSK3B, IGF1R, PPARA, PTGS2, RELA, SRC, TRPV1 |
3.63763 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, KDR, SRC, TRPV1 |
3.62513 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, TRPV1 |
3.58576 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, FLT3, GSK3B, IGF1R, NR3C1, PTGS2, RELA, SRC, TRPV1 |
3.58092 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, HSD11B1, HSD17B3, PTGES, PTGS2 |
3.52686 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CACNA1C, CYP19A1, FLT3, HSD11B1, HSD17B3, KDR, MAP2K1, PPARA, RELA, SRC |
3.5166 |
[BP] GO:0048545 |
response to steroid hormone
|
AR, CA2, FLT3, NR3C1, PTGS2, RELA, SRC |
3.50305 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, CYP1B1, FABP3, IDO1, MAP2K1, PTGES, PTGS2, XDH |
3.4822 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1B1, DHFR, FABP3, IDO1, PIM1, PPARA, PTGES, PTGS2 |
3.47137 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DHFR, FABP3, KDR, PTGES, PTGS2, RELA, SRC |
3.46297 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AXL, CA2, CACNA1C, CYP19A1, CYP1B1, DHFR, FLT3, GSK3B, HSD11B1, HSD17B3, KDR, MAP2K1, PIM1, PPARA, PTGS2, RELA, SRC |
3.46033 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, APP, F10, F3, IGF1R, KDR, MET, PTGS2, SRC |
3.43149 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, AR, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, SRC, XDH |
3.41534 |
[BP] GO:1901570 |
None
|
ALOX12, ALOX15, ALOX5, PTGES, PTGS2 |
3.41499 |
[BP] GO:0033993 |
response to lipid
|
AR, AXL, CA2, FABP3, FLT3, IDO1, NR3C1, PTGES, PTGS2, RELA, SRC |
3.40491 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, F10, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, SRC, TOP1 |
3.4015 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, APP, F10, F3, IGF1R, KDR, MET, PTGS2, SRC |
3.32261 |
[BP] GO:0019371 |
None
|
CBR1, PTGES, PTGS2 |
3.31668 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ALOX12, APP, AR, AXL, CA2, CYP1B1, F3, IDO1, KDR, MAP2K1, PIM1, PTGS2, RELA, SRC |
3.26108 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, APP, F10, F3, IGF1R, KDR, MET, PTGS2, SRC |
3.24035 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APP, AR, CYP1B1, FLT3, NR3C1, PTGS2, SRC, TRPV1 |
3.23401 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, APP, CYP19A1, CYP1B1, CYP3A4, HSD11B1, HSD17B3 |
3.22029 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CACNA1C, KDR, PTGS2, SRC, TRPV1 |
3.22029 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AR, AURKB, CYP1B1, DHFR, F3, FABP4, FLT3, GRIN2B, GSK3B, IGF1R, MAP2K1, MAP3K7, MET, PIM1, PPARA, PTGS2, RELA, SRC, TRPV1, XDH |
3.18873 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, APP, F10, F3, IGF1R, KDR, MET, PTGS2, SRC |
3.14409 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1B1, DHFR, FABP3, IDO1, PIM1, PPARA, PTGES, PTGS2 |
3.1095 |
[BP] GO:0046394 |
None
|
ALOX12, ALOX15, ALOX5, DHFR, IDO1, PTGES, PTGS2 |
3.03999 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1B1, DHFR, FABP3, IDO1, PIM1, PPARA, PTGES, PTGS2 |
3.03695 |
[BP] GO:0016053 |
None
|
ALOX12, ALOX15, ALOX5, DHFR, IDO1, PTGES, PTGS2 |
3.03535 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1B1, CYP3A4, HSD11B1, HSD17B3 |
3.01439 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
3.00629 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
3.00629 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
3.00629 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, GSK3B, IGF1R, PTGS2, RELA, SRC, TRPV1 |
2.91918 |
[BP] GO:0042391 |
None
|
ADORA1, APP, CACNA1C, GRIN2B, KCNH2, KDR, SRC, TRPV1 |
2.88791 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA, SRC |
2.88165 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1B1, CYP3A4, HSD17B3 |
2.88165 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, RELA, SRC |
2.88165 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, FABP3, PPARA, TRPV1 |
2.81477 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, DHFR, F3, FABP3, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, NR3C1, PPARA, PTGS2, RELA, SRC, TRPV1, XDH |
2.81477 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, F3, FABP3, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, NR3C1, PPARA, PTGS2, RELA, SRC, TRPV1, XDH |
2.77671 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, APP, AXL, CA2, CA7, CACNA1C, CYP19A1, GSK3B, KCNH2, MAP2K1, PPARA, PTGS2, SRC, TRPV1 |
2.72438 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1B1, CYP3A4, DHFR, F10, F3, FABP3, FABP4, FLT3, GRIN2B, GSK3B, HSD11B1, HSD17B3, IDO1, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, PTGS2, RELA, SRC, TOP1, TRPV1, XDH |
2.71066 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, ALOX12, MET, TRPV1 |
2.71066 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, GSK3B, IGF1R, PTGS2, RELA, SRC, TRPV1 |
2.70227 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CYP1B1, F10, F3, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PTGS2, RELA, SRC, XDH |
2.69618 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, RELA |
2.68313 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, GSK3B, MET, PPARA, SRC |
2.6814 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, PTGS2 |
2.67084 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, AXL, PTGES, PTGS2, RELA, TRPV1 |
2.66448 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APP, GSK3B, IGF1R, RELA, SRC |
2.65337 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC |
2.64401 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
ALOX12, APP, AR, AXL, CA2, CYP1B1, F3, GSK3B, IDO1, KDR, MAP2K1, PIM1, PTGS2, RELA, SRC, XDH |
2.62696 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, F10, F3, MET, SRC, XDH |
2.62696 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.611 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B3 |
2.611 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.611 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.57616 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, AR, FABP3, FLT3, KDR, MAP2K1, MAP3K7, PTGS2, SRC, XDH |
2.56739 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, AR, FABP3, FLT3, KDR, MAP2K1, MAP3K7, PTGS2, SRC, XDH |
2.56739 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AR, AURKB, AXL, CA2, CACNA1C, CBR1, CYP19A1, CYP1B1, DHFR, FABP4, FLT3, GSK3B, HSD11B1, HSD17B3, KDR, MAP2K1, MET, PIM1, PPARA, PTGS2, RELA, SRC |
2.5632 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, AR, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PPARA, PTGS2, SRC, XDH |
2.54913 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AR, AXL, CA1, CA2, CACNA1C, CYP1B1, F3, FLT3, GRIN2B, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, RELA, SRC, TRPV1 |
2.54126 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, AR, AURKB, F3, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, NR3C1, PPARA, PTGS2, RELA, SRC, TRPV1, XDH |
2.5172 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, AR, FABP3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PPARA, PTGS2, SRC, XDH |
2.50025 |
[BP] GO:0035556 |
intracellular signal transduction
|
AKR1B1, AXL, CACNA1C, CYP1B1, GRIN2B, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, RELA, SRC |
2.48714 |
[BP] GO:0050793 |
regulation of developmental process
|
ALOX12, APP, AR, AXL, CA2, CYP1B1, F3, GSK3B, IDO1, KDR, MAP2K1, PIM1, PPARA, PTGS2, RELA, SRC, TRPV1, XDH |
2.48459 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, AR, FLT3, KDR, MAP2K1, MAP3K7, PTGS2, SRC, XDH |
2.4823 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, CA2, CYP1B1, DHFR, GSK3B, IDO1, MAP2K1, MAP3K7, PPARA, PTGES, PTGS2, RELA, SRC, TRPV1 |
2.47596 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, AR, FABP3, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PPARA, PTGS2, SRC, XDH |
2.47493 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, CYP1B1, PTGS2, RELA, SRC |
2.46979 |
[BP] GO:0042180 |
None
|
AKR1B1, CYP19A1, HSD17B3, IDO1 |
2.44681 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, GSK3B, KCNH2, PTGS2, SRC, TRPV1 |
2.4246 |
[BP] GO:0071345 |
cellular response to cytokine stimulus
|
ALOX15, AXL, FABP4, FLT3, GSK3B, RELA, TRPV1 |
2.38342 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CYP1B1, FABP4, GSK3B, IGF1R, MET, PIM1, PPARA, PTGS2, SRC |
2.36534 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.3645 |
[BP] GO:0071383 |
None
|
AR, FLT3, NR3C1, SRC |
2.34389 |
[BP] GO:0072330 |
monocarboxylic acid biosynthetic process
|
ALOX12, ALOX15, IDO1, PTGES, PTGS2 |
2.34331 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, KDR, NR3C1, RELA, SRC, TRPV1 |
2.34331 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, AR, FLT3, KDR, MAP2K1, MAP3K7, PTGS2, SRC, XDH |
2.33969 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, AR, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, PTGS2, SRC, XDH |
2.33969 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, APP, AR, AURKB, AXL, CYP3A4, DHFR, F10, F3, FLT3, GRIN2B, GSK3B, IDO1, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, PIM1, PPARA, PTGS2, RELA, SRC, TOP1, XDH |
2.33969 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DHFR, GSK3B, IGF1R, MAP2K1, MAP3K7, MET, PTGS2, XDH |
2.33969 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.31075 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F10, F3, MET, SRC |
2.30333 |
[BP] GO:0010942 |
positive regulation of cell death
|
CYP1B1, F3, GRIN2B, GSK3B, IDO1, PTGS2, SRC, TRPV1, XDH |
2.28617 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
ALOX12, CYP1B1, F3, KDR, PTGS2 |
2.28028 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, HSD17B3 |
2.27031 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DHFR, MAOA, PTGS2, TRPV1 |
2.27002 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, AR, F3, FLT3, GSK3B, KDR, MAP2K1, MAP3K7, PTGS2, RELA, SRC, XDH |
2.27002 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, CACNA1C, FABP3, GRIN2B, KCNH2, TRPV1 |
2.25764 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX12, ALOX15, CYP1B1, GSK3B, IDO1, KDR, MAP3K7, PPARA, SRC |
2.25764 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, NR3C1, SRC |
2.22377 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CBR1, CYP1B1, CYP3A4, DHFR, IDO1, MAOA |
2.20059 |
[BP] GO:1904645 |
response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.20059 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, MAP3K7, PIM1, RELA |
2.20059 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, FABP4, IDO1, PPARA, PTGS2, RELA |
2.20059 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, PTGS2 |
2.20059 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.20059 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.20059 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.20059 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.20059 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.20059 |
[BP] GO:0006691 |
None
|
ALOX12, ALOX15, ALOX5 |
2.16583 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, HSD17B3, MAP2K1, SRC |
2.16369 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, CYP19A1, CYP1B1, CYP3A4, FABP3, FABP4 |
2.16369 |
[BP] GO:0006633 |
None
|
ALOX12, ALOX15, PTGES, PTGS2 |
2.15004 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7 |
2.13575 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, ALOX12, F10, F3, MET, XDH |
2.13575 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, DHFR, PTGS2, TRPV1, XDH |
2.13575 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, CYP1B1, GRIN2B, KDR, RELA, SRC |
2.12566 |
[BP] GO:0042133 |
neurotransmitter metabolic process
|
ACHE, CYP1B1, DHFR, MAOA |
2.12357 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
AXL, IDO1, PTGES, PTGS2, RELA, SRC |
2.12033 |
[BP] GO:0043434 |
None
|
FABP3, PPARA, PTGS2, RELA, SRC, TRPV1 |
2.11463 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
F3, FABP4, IDO1, KDR, MET, PTGS2 |
2.1101 |
[BP] GO:0070848 |
response to growth factor
|
APP, KDR, NR3C1, RELA, SRC, TRPV1 |
2.1101 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, F3, FLT3, GRIN2B, GSK3B, IGF1R, KDR, MAP3K7, MET, RELA, SRC, TRPV1 |
2.10715 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, AR, F3, FLT3, IGF1R, KDR, PIM1, PTGS2, RELA |
2.10715 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, RELA, SRC |
2.09514 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX12, ALOX15, AR, CYP19A1, GSK3B, IGF1R, MET, PPARA, PTGS2, RELA, SRC, XDH |
2.08681 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
ALOX12, CYP1B1, F3, KDR, PTGS2 |
2.08681 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, NR3C1, RELA, SRC |
2.05542 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, DHFR, PPARA |
2.04565 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, FABP3, GRIN2B, KCNH2, PPARA, TRPV1 |
2.01344 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.69169 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, APP, AR, AURKB, CA1, CA2, CA4, CA7, CACNA1C, CBR1, CYP19A1, CYP1B1, CYP3A4, DHFR, F10, FABP3, FABP4, FLT3, GSK3B, HSD11B1, HSD17B3, IDO1, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, NR3C1, PIM1, PTGES, PTGS2, RELA, SRC, TOP1, TRPV1, XDH |
3.18873 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, APP, AR, AXL, CA12, CA14, CA2, CA4, CACNA1C, F10, F3, FLT3, GRIN2B, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TRPV1 |
3.14801 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALOX5, APP, AR, AXL, CA12, CA14, CA2, CA4, CACNA1C, CYP19A1, CYP1B1, CYP3A4, F10, F3, FLT3, GRIN2B, GSK3B, HSD11B1, HSD17B3, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, PIM1, PTGES, PTGS2, SRC, TRPV1 |
2.62696 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.62536 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ALOX15, APP, AXL, CA2, CA4, CACNA1C, F10, F3, FLT3, GRIN2B, IGF1R, KCNH2, KDR, MET, PTGS2, SRC, TRPV1 |
2.52772 |
[CC] GO:0009986 |
cell surface
|
ACHE, APP, AXL, CA4, F3, GRIN2B, KCNH2, MET |
2.13933 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, F10, F3, FLT3, GRIN2B, IGF1R, KDR, MET, TRPV1 |
2.12566 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1B1, CYP3A4, DHFR, F10, F3, FABP3, FABP4, FLT3, GRIN2B, GSK3B, IDO1, IGF1R, KDR, MAP2K1, MAP3K7, MET, NR3C1, PIM1, PPARA, PTGES, PTGS2, RELA, SRC, TOP1, TRPV1, XDH |
8.87041 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
8.04991 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CBR1, CYP19A1, CYP1B1, CYP3A4, DHFR, F10, F3, FLT3, GSK3B, HSD11B1, HSD17B3, IDO1, IGF1R, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, PIM1, PTGES, PTGS2, SRC, TOP1, XDH |
7.18905 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, APP, AR, CA1, CA12, CA2, CA4, CA7, CYP19A1, CYP1B1, CYP3A4, GRIN2B, NR3C1, PIM1, PPARA, XDH |
6.72415 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX12, ALOX15, ALOX5, CBR1, CYP19A1, CYP1B1, CYP3A4, DHFR, HSD11B1, HSD17B3, IDO1, MAOA, PTGS2, XDH |
6.28562 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CYP19A1, CYP1B1, CYP3A4, DHFR, FLT3, GRIN2B, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PPARA, SRC, TOP1, TRPV1 |
5.46686 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
5.39766 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5, IDO1, PTGS2 |
5.39766 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5, IDO1, PTGS2 |
5.32148 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, FLT3, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
5.24492 |
[MF] GO:0043168 |
anion binding
|
ALOX15, APP, AURKB, AXL, DHFR, F10, F3, FABP3, FABP4, FLT3, GRIN2B, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PTGES, RELA, SRC, TOP1, TRPV1, XDH |
5.08627 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
4.75174 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, FLT3, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
4.53185 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, CYP3A4, F10, F3, FABP3, FABP4, NR3C1, PPARA, SHBG, TRPV1 |
4.34454 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, CYP19A1, CYP1B1, CYP3A4, XDH |
4.2244 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, FLT3, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
4.16734 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.93714 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.84801 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1B1, CYP3A4, IDO1, PTGS2, SRC |
3.65723 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1B1, CYP3A4, F10, GRIN2B, IDO1, MAP3K7, NR3C1, PIM1, PPARA, PTGS2, TRPV1, XDH |
3.64498 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, FLT3, GSK3B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1 |
3.5166 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1B1, CYP3A4, IDO1, PTGS2, SRC |
3.50305 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.43149 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CACNA1C, CYP19A1, CYP1B1, CYP3A4, F10, GRIN2B, IDO1, MAP3K7, NR3C1, PIM1, PPARA, PTGS2, TRPV1, XDH |
3.31668 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, IGF1R, NR3C1, SHBG |
3.30502 |
[MF] GO:0051213 |
dioxygenase activity
|
ALOX12, ALOX15, ALOX5, IDO1, PTGS2 |
3.20202 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1B1, CYP3A4, DHFR, IDO1, PTGES, PTGS2, SRC, XDH |
3.17412 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, F3, FLT3, GRIN2B, IGF1R, KCNH2, KDR, MAP2K1, MAP3K7, MET, NR3C1, PPARA, TRPV1 |
3.11734 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, DHFR, FABP3, FABP4, FLT3, GRIN2B, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1, TRPV1, XDH |
3.00714 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
3.00629 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, F3, FLT3, GRIN2B, IGF1R, KCNH2, KDR, MET, NR3C1, PPARA, TRPV1 |
2.91068 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7 |
2.91068 |
[MF] GO:0050473 |
arachidonate 15-lipoxygenase activity
|
ALOX15, PTGS2 |
2.611 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.611 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.611 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, CBR1, HSD11B1, HSD17B3, XDH |
2.48459 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1B1, CYP3A4 |
2.4823 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, F3, FLT3, GRIN2B, IGF1R, KCNH2, KDR, MET, NR3C1, PPARA, TRPV1 |
2.43189 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.3645 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1B1, CYP3A4 |
2.34389 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, F3, FLT3, GRIN2B, IGF1R, KCNH2, KDR, MET, NR3C1, PPARA, TRPV1 |
2.31075 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, NR3C1, SHBG |
2.15004 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1, TRPV1 |
2.11463 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.06578 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1, TRPV1 |
2.02996 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, FLT3, GSK3B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TOP1, TRPV1 |
2.00431 |